According to a report on 06/03/2026, Cigna said that beginning 07/01/2026 it will discontinue coverage of GLP-1 weight-loss medications, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound, for roughly 67,700 employees in its U.S
Purpose-built for physicians GLP-1 use before pregnancy may raise preeclampsia risk, lower gestational diabetes risk Key takeaways: Women who used a GLP-1 before pregnancy were more likely to develop preeclampsia than nonusers
Novel antihypertensive action of rutin is mediated via inhibition of angiotensin converting enzyme/mineralocorticoid receptor/angiotensin 2 type 1 receptor (ATR1) signaling pathways in uninephrectomized hypertensive rats
Kushner RF, Ryan DH, Deanfield J, et al
Lawnwood Circle makes in-person support easy for patients in Fort Pierce, St